COGT
Cogent Biosciences Inc
31.40$
-3.7%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +112.8% | +31.5% | +16.4% | +131.1% | -65.0% | -100.0% | – | – | – | – | |
| – | – | – | – | – | +58,784.9% | -99.4% | +3,898.6% | -39.0% | +22.7% | +5.0% | |
| – | +112.8% | +31.5% | +16.4% | +131.1% | -179.4% | – | – | – | – | – | |
| – | +221.0% | +35.6% | +28.3% | +14.2% | +66.2% | -23.0% | +117.5% | +42.9% | +33.9% | +16.0% | |
| – | +25.9% | +36.3% | +59.3% | +47.1% | +58.8% | +12.7% | +33.5% | +31.1% | +25.9% | +46.9% | |
| – | +165.5% | +35.7% | +32.5% | +19.5% | +17.7% | +17.4% | +95.7% | +40.8% | +32.6% | +19.1% | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | +2,074.3% | +27.4% | -100.0% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -205.9% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.